LC-30

N/A

Report date: 2025/06/11 10:17:24
NME

Base Information

Drug NameLC-30
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionMyc proto-oncogene protein modulators
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnticancer Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnticancer Bioscience Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A